approved EB-2 (NIW)

Senior Scientist

Protein Science And Biopharmaceuticals · China · 2024-03-20

Processing Time
5 days
Decision Date
2024-03-20
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on developing biomanufacturing processes to produce therapeutic moieties such as biologics, small molecules, and cell and gene therapies. Her work focuses on achieving optimal-quality treatments for diseases including cancer, inflammation, and rare diseases while expanding the availability of top-tier therapies through biomanufacturing innovations.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor focuses on improving biomanufacturing processes for life-saving therapies, which addresses the high cost and scarcity of cancer medications.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. in chemical engineering and has a record of peer-reviewed publications and citations supported by federal agencies.

3 Waiver of Job Offer and Labor Certification Met

The USCIS determined that the petitioner's contributions to biomanufacturing and disease treatment access provide a significant benefit to the U.S. national interest.

Why This Petition Was Approved

The petition was approved based on the petitioner's 5 peer-reviewed journal articles (4 first-authored) which garnered 20 citations, demonstrating her influence in the field. Her work is supported by federal funding from the National Institute of Innovation in Manufacturing Biopharmaceuticals and the Defense Threat Reduction Agency, and she provided 4 expert recommendation letters confirming her technical expertise in machine learning and biochemical assays.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
North Carolina 12 days 2025-01-22
The petitioner proposes to continue research on engineering microorganisms for the biomanufacturing of valuable chemicals and pharmaceutical ingredients. This work focuses on establishing cost-effective domestic supply chains for essential compounds within the U.S. biotechnology sector.

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.

Postdoctoral Researcher

Research and Development · Mexico

WeGreened EB-2 (NIW) approved
Colorado 425 days 2022-03-26
The petitioner proposes to synthesize and test novel compounds designed to stabilize HIF transcription factors. This work aims to develop new therapeutic applications for the treatment of inflammatory diseases and to improve wound healing processes.

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-03-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist